...
首页> 外文期刊>Filaria journal >Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a
【24h】

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a

机译:南印度本地治里无症状微丝尿素血症志愿者中单剂量阿苯达唑,柠檬酸二乙基卡巴咪嗪(DEC)或阿苯达唑与DEC并用在清除无性微丝虫的Wuchereria bancrofti中的耐受性和功效:

获取原文
           

摘要

Background The tolerability and efficacy of single dose albendazole (400 mg), diethylcarbamazine citrate (DEC) (6 mg/kg bodyweight) or co-administration of albendazole (400 mg) + DEC (6 mg/kg bodyweight) was studied in 54 asymptomatic Wuchereria bancrofti microfilaraemic volunteers in a double blind hospital-based clinical study. Results There was no significant difference in the overall incidence of adverse reactions between the three drug groups [42.1% (albendazole), 52.9% (DEC) and 61.1% (albendazole + DEC); P > 0.05]. The mean score of adverse reaction intensity did not differ significantly between the DEC and albendazole + DEC groups. However, the values in these two groups were significantly higher compared to that of albendazole alone [1.8 ± 3.0 (albendazole) vs. 5.6 ± 7.1 (DEC), 6.7 ± 6.6 (albendazole + DEC); P < 0.05]. By day 360 post-therapy there was no significant difference between the three drug groups in relation to the clearance of microfilaria [26.3% (albendazole), 17.6% (DEC), 27.8% (albendazole + DEC)], reduction in geometric mean parasite density [94.7% (albendazole), 89.5% (DEC), 95.4% (albendazole + DEC)] or reduction in filarial antigenaemia [83% (albendazole), 87% (DEC), 75% (albendazole + DEC)]. Furthermore, there was a significant decrease in mean geometric parasite density (P < 0.05) as well as antigenaemia optical density values (P < 0.01) between pre-therapy levels and day 360 post-therapy in all three groups. Conclusions This study has shown that single dose albendazole (400 mg) has similar efficacy in the clearance of microfilaria as that of DEC or the co-administration of the two drugs. The results strengthen the rationale of using albendazole for mass annual single dose administration for the control of transmission of lymphatic filariasis.
机译:背景在54例无症状患者中研究了单剂量阿苯达唑(400 mg),柠檬酸二乙基卡巴嗪(DEC)(6 mg / kg体重)或阿苯达唑(400 mg)+ DEC(6 mg / kg体重)的联合给药的耐受性和疗效。 Wuchereria bancrofti微丝菌素志愿者在基于双盲医院的临床研究中。结果三种药物的不良反应总发生率没有显着差异[42.1%(阿苯达唑),52.9%(DEC)和61.1%(阿苯达唑+ DEC); P> 0.05]。 DEC组和阿苯达唑+ DEC组之间的不良反应强度的平均得分没有显着差异。但是,两组的值均明显高于单独的阿苯达唑[1.8±3.0(阿苯达唑)与5.6±7.1(DEC),6.7±6.6(阿苯达唑+ DEC); P <0.05]。到治疗后第360天,三种药物组之间在清除微丝aria病方面无显着差异[26.3%(阿苯达唑),17.6%(DEC),27.8%(阿苯达唑+ DEC)],几何平均寄生虫减少密度[94.7%(阿苯达唑),89.5%(DEC),95.4%(阿苯达唑+ DEC)]或降低丝状抗原血症[83%(阿苯达唑),87%(DEC),75%(阿苯达唑+ DEC)]。此外,在三组治疗前水平和治疗后第360天之间,平均几何寄生虫密度(P <0.05)以及抗原性贫血光学密度值(P <0.01)显着降低。结论这项研究表明,单剂量阿苯达唑(400毫克)在清除微丝aria病方面的疗效与DEC或两种药物的共同给药相似。该结果加强了使用阿苯达唑进行大规模年度单剂量给药以控制淋巴丝虫病传播的基本原理。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号